Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 811 AL 825

Tau as a Biomarker of Neurodegeneration

Holper S, Watson R, Yassi N.

Int J Mol Sci. 2022 Jun 30;23(13):7307. doi: 10.3390/ijms23137307.

Peptidomic Approaches and Observations in Neurodegenerative Diseases

Muqaku B, Oeckl P.

Int J Mol Sci. 2022 Jun 30;23(13):7332. doi: 10.3390/ijms23137332.

A Comparison of Operational Definitions for Mild Cognitive Impairment

Polcher A, Wolfsgruber S, Peters O, Frölich L, Wiltfang J, Kornhuber J, Hüll M, Rüther E, Lewczuk P, Maier W, Jessen F, Wagner M.

J Alzheimers Dis. 2022;88(4):1663-1678. doi: 10.3233/JAD-215548.

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity

Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer's Disease Project Team.

Alzheimers Dement. 2023 Mar;19(3):956-966. doi: 10.1002/alz.12697. Epub 2022 Jul 12.

The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow

Lorenzini L, Ingala S, Wink AM, Kuijer JPA, Wottschel V, Dijsselhof M, Sudre CH, Haller S, Molinuevo JL, Gispert JD, Cash DM, Thomas DL, Vos SB, Prados F, Petr J, Wolz R, Palombit A, Schwarz AJ, Chételat G, Payoux P, Di Perri C, Wardlaw JM, Frisoni GB, Foley C, Fox NC, Ritchie C, Pernet C, Waldman A, Barkhof F, Mutsaerts HJMM; EPAD consortium.

Neuroimage Clin. 2022;35:103106. doi: 10.1016/j.nicl.2022.103106. Epub 2022 Jul 7.

Clinical Research Investigating Alzheimer's Disease in China: Current Status and Future Perspectives Toward Prevention

Wang Q, Gao F, Dai LN, Zhang J, Bi D, Shen Y.

J Prev Alzheimers Dis. 2022;9(3):532-541. doi: 10.14283/jpad.2022.46.

Insights for Alzheimer's disease pharmacotherapy and current clinical trials

Nascimento ALCS, Fernandes RP, Carvalho ACS, Frigieri I, Alves RC, Chorilli M.

Neurochem Int. 2022 Oct;159:105401. doi: 10.1016/j.neuint.2022.105401. Epub 2022 Jul 13.

Ventricular volume in relation to lumbar CSF levels of amyloid-β 1-42, tau and phosphorylated tau in iNPH, is there a dilution effect?

Lidén S, Farahmand D, Laurell K.

Fluids Barriers CNS. 2022 Jul 17;19(1):59. doi: 10.1186/s12987-022-00353-9.

Cerebrospinal Fluid Synaptosomal-Associated Protein 25 Levels in Patients with Alzheimer's Disease: A Meta-Analysis

Liu Q, Liu H, Zhang S, Yang Q, Shen L, Jiao B.

J Alzheimers Dis. 2022;89(1):121-132. doi: 10.3233/JAD-215696.

The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia

Alty J, Bai Q, Li R, Lawler K, St George RJ, Hill E, Bindoff A, Garg S, Wang X, Huang G, Zhang K, Rudd KD, Bartlett L, Goldberg LR, Collins JM, Hinder MR, Naismith SL, Hogg DC, King AE, Vickers JC.

BMC Neurol. 2022 Jul 18;22(1):266. doi: 10.1186/s12883-022-02772-5.

Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults

Demnitz-King H, Gonneaud J, Klimecki OM, Chocat A, Collette F, Dautricourt S, Jessen F, Krolak-Salmon P, Lutz A, Morse RM, Molinuevo JL, Poisnel G, Touron E, Wirth M, Walker Z, Chételat G, Marchant NL; Medit-Ageing Research Group.

Neurology. 2022 Sep 27;99(13):e1422-e1431. doi: 10.1212/WNL.0000000000200951. Epub 2022 Jul 19.

Alzheimer's disease: a scoping review of biomarker research and development for effective disease diagnosis

Faldu KG, Shah JS.

Expert Rev Mol Diagn. 2022 Jul;22(7):681-703. doi: 10.1080/14737159.2022.2104639. Epub 2022 Jul 28.

[Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer's Dementia]

Hansen N, Rauter C, Wiltfang J.

Fortschr Neurol Psychiatr. 2022 Jul;90(7-08):326-335. doi: 10.1055/a-1839-6237. Epub 2022 Jul 20.

Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

Timsina J, Gomez-Fonseca D, Wang L, Do A, Western D, Alvarez I, Aguilar M, Pastor P, Henson RL, Herries E, Xiong C, Schindler SE, Fagan AM, Bateman RJ, Farlow M, Morris JC, Perrin RJ, Moulder K, Hassenstab J, Vöglein J, Chhatwal J, Mori H; Alzheimer’s Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network Consortia; Sung YJ, Cruchaga C.

J Alzheimers Dis. 2022;89(1):193-207. doi: 10.3233/JAD-220399.

Biomarkers for Alzheimer's Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation

Cummings J, Kinney J.

Medicina (Kaunas). 2022 Jul 19;58(7):952. doi: 10.3390/medicina58070952.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias